Viewing Study NCT06989567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-25 @ 5:04 AM
Study NCT ID: NCT06989567
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-29
First Post: 2025-05-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
Sponsor: Asklepion Pharmaceuticals, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sickle cell disease View
None citrulline View
None Vaso-Occlusive Crisis View
None Pain Crisis Relief in Sickle Cell Disease View
None Children and Adolescents with Sickle Cell View